These small cap ASX shares surged more than 100% in February

From a new BNPL agreement to cancer detection, these 3 small cap ASX shares made game changing announcements in February.

| More on:
A man stands with arms crossed in front of a giant shadow of a body builder representing ASX small-cap stocks.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The small-cap space is always filled with explosive ASX shares looking to emerge as the next big thing. Here are the small-cap ASX shares that made headlines in February. 

1. Province Resources Ltd (ASX: PRL

The Province Resources share price surged an eye-watering 460% on 17 February. It's a Cinderella story for a small-cap ASX share to announce the right kind of acquisition at a time where there is significant investor appetite for green projects. 

The company announced its intention to acquire Ozexco Pty Ltd. Ozexco holds 7 exploration licenses in the Gascoyne region in Western Australia, a region that is also one of the hottest and windiest areas with significant solar and wind potential. 

The initial exploration and evaluation will be focused on the salt, potash, mineral sands and renewable hydrogen potential over the tenement area. This would make Province the first listed green hydrogen player on the ASX. 

After surging from 2.6 cents to 14.5 cents in just one day, its shares have cooled down to close at 9 cents today. 

2. BARD1 Life Sciences Ltd (ASX: BD1) 

The BARD1 share price found itself running as high as 650% in just six days after the company announced that it's SubB2M technology could detect all stages of ovarian cancer and disease recurrence.

BARD1 CSO Dr Peter French said:

Whilst this data is preliminary, these excellent results reported by the researchers at Griffith University support the commercial potential of SubB2M for both breast and ovarian cancer monitoring and detection.

This is ground-breaking research since Neu5Gc is a highly specific marker for cancer and BARD1 is using SubB2M alone or in combination with other tissue-specific cancer markers to develop highly-specific tests for breast, ovarian, prostate and pancreatic cancers.

BARD1 plans to develop and commercialise SUbB2M-based blood tests initially for monitoring patients already diagnosed with breast cancer for treatment response and recurrence.

The company expects to report the outcomes of its SubB2M test validation studies by the end of Q3 CY21. 

3. Ioupay Ltd (ASX: IOU) 

Ioupay was arguably the dark horse of the buy now, pay later (BNPL) sector. While BNPL shares across the board were surging at the beginning of February, Ioupay was quietly waiting to announce a game-changer. 

On 9 February, the company announced that it had entered into a Merchant Referral Agreement with EasyStore Commerce to enable EasyStore's merchants and end-user customers to utilise Ioupay's BNPL payment services. 

EasyStore services more than 7,000 merchants across the South East Asian (SEA) markets, including Malaysia, Singapore, Indonesia, Philippines, Thailand, Hong Kong and Taiwan. Some 5,000 of these are in Malaysia, with a growing portfolio of merchants in the US. 

In 2020, EasyStore merchants processed a total transaction volume of approximately $435 million. The two companies have started integrating systems with BNPL payment processing capabilities to begin onboarding merchants and approved customers by early March this year. 

It was almost as if the words 'buy now, pay later' were enough to send its shares into a buying frenzy. By 18 February, the ioupay share price had ripped 280% higher to a high of 85 cents before management decided it was time to announce a $50 million placement to support its growth initiatives further. 

Motley Fool contributor Kerry Sun has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Market News

Animation of a man measuring a percentage sign, symbolising rising interest rates.
Share Market News

Here's when Westpac says the RBA will now cut interest rates

Will borrowers need to wait until the middle of next year for relief? Let's find out.

Read more »

Boys making faces and flexing.
Opinions

3 ASX 300 shares to buy and hold for the long run

I believe these stocks have loads of growth potential.

Read more »

Young girl drinking milk showing off muscles.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a great end to the trading week for ASX investors today.

Read more »

Hands reaching high for a trophy with a sunset in the background.
Record Highs

The ASX 200 Index is on its way to another all-time high today. Here's why

These blue chip stocks are driving the index towards a new record today...

Read more »

Group of friends trading stocks on their phones. symbolising the 3 most traded ASX 200 shares today
Share Market News

3 ASX mining stocks topping the most-traded list in October

Chinese stimulus news and company announcements likely contributed to the higher trading activity.

Read more »

A man sits thoughtfully on the couch with a laptop on his lap.
Share Gainers

3 ASX 200 stocks smashing the benchmark this week

These three ASX 200 stocks are leading the charge this week. Here’s how.

Read more »

Two people tired and resting after sports race.
Broker Notes

Fundie rates 2 ASX 200 stocks in short-term pain but with long-term gain potential

Blackwattle Investment Partners sees these 2 ASX 200 stocks as worthy of a buy and hold strategy.

Read more »

A young woman holding her phone smiles broadly and looks excited, after receiving good news.
Share Gainers

Why A2 Milk, EOS, GQG, and Mineral Resources shares are racing higher today

These shares are ending the week strongly. But why?

Read more »